Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study
曲妥珠单抗德鲁替康作为HER2突变转移性非小细胞肺癌患者二线或后续治疗的真实世界疗效:一项回顾性研究
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-916
Huang, Kuofang; Hu, Zhihuang; Pan, Shifei; Qian, Jialin; Wu, Xianghua; Wang, Huijie; Wang, Kai; Lu, Haijiao; Dong, Huishu; Chu, Tianqing; Wang, Jialei